Ophthalmic Viscosurgical Devices Market (2026 - 2033)

Ophthalmic Viscosurgical Devices Market Summary

The global ophthalmic viscosurgical devices market size was valued at USD 479.8 million in 2025 and is projected to grow from USD 521.1 million in 2026 to USD 738.0 million by 2033, at a CAGR of 5.1% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 37.7% in 2025. The global population is aging, leading to a surge in age-related eye diseases such as cataracts, glaucoma, and macular degeneration.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

According to WHO,the global population aged 60 and over will surge from 900 million in 2015 to 2 billion by 2050, representing a rapid shift from 12% to 22% of the total population. Diabetes is a significant risk factor for eye complications, increasing the demand for ophthalmic surgeries. Increased patient awareness regarding eye health and available treatments has led to higher rates of diagnosis and treatment for ocular disorders.

To learn more about this report, Download Free Sample Report

Innovations in ophthalmic surgery techniques, including minimally invasive procedures, enhance the effectiveness and safety of surgeries. These advancements often require specialized OVDs that can improve surgical outcomes and reduce complications. Increased public awareness about eye care is encouraging early diagnosis and treatment of eye diseases. The establishment of specialized ophthalmic centers is further fueling the market growth.

Market Dynamics

The ophthalmic viscosurgical devices market is witnessing steady growth due to increased use by ophthalmic surgeons of viscoelastic substances in order to perform safe anterior segment surgeries while ensuring protection of intraocular tissues. Ophthalmic viscosurgical devices or OVDs refer to sterile viscoelastic substances, mainly based on hyaluronic acid, chondroitin sulfate, hydroxypropyl methylcellulose and other biocompatible polymers used to maintain anterior chamber depth, protect corneal endothelium, stabilize ocular tissues, and facilitate handling of intraocular tissues during surgeries. Ophthalmic viscosurgical devices consist of dispersive, cohesive and viscoadaptive products, providing an opportunity for performing various kinds of ophthalmic surgeries, such as cataract surgery, glaucoma surgery, corneal grafting, vitreoretinal surgery, etc. Increasing prevalence of cataracts, glaucoma, diabetic retinopathy and age-related ocular disorders, as well as increasing amount of surgeries and availability of ophthalmic surgeries, is stimulating market growth. In addition, advances in viscoelastic compositions, rheological properties, increased tissue protection and combination polymer technology ensure enhanced performance of surgeries and better treatment results. Investments in surgery infrastructure, increasing usage of premium intraocular lenses and increasing number of minimally invasive ophthalmic surgeries drive the demand for more advanced ophthalmic viscosurgical devices.

Analyst Perspective

The ophthalmic viscosurgical devices market is positioned at the intersection of increasing global ophthalmic surgery volumes, technological advancements in intraocular procedures, and the growing demand for precision surgical outcomes. Growing aging population, higher prevalence of cataracts and glaucoma, and greater availability of advanced ophthalmic surgeries are driving the requirement of high-quality viscoelastics. Increasingly, manufacturers are paying attention to the development of new generation viscoelastics with superior rheological properties, high-end protection of the endothelial cells, stable chamber performance, and easy removal capability. Also, ongoing trend in premium intraocular lenses implantations, femtosecond laser cataract surgery, and minimally invasive glaucoma surgery will further provide scope for innovations in the market.

Type Insights

Based on type, the dispersive segment led the market with the largest revenue share of 37.2% in 2025. This is due to their ability to provide effective protection to corneal endothelial cells during cataract surgery. These devices create a stable viscoelastic environment that helps maintain intraocular pressure and prevents damage to delicate tissues. The growing incidence of cataracts, particularly among the aging population, has led to a higher demand for surgical interventions where dispersive OVDs play a crucial role.

The viscoadaptive segment is anticipated to witness the fastest CAGR of 7.7% over the forecast period. This growth is attributed to their unique ability to adapt their viscosity based on shear stress during surgical manipulation. This adaptability allows for enhanced control during procedures such as phacoemulsification and intraocular lens implantation. As surgeons increasingly seek tools that offer precision and ease of use, viscoadaptive OVDs have become a preferred choice.

Source Insights

Based on source, the biological segment led the market with the largest revenue share of 39.8% in 2025. This is due to their biocompatibility and enhanced performance during ocular surgeries. Derived from natural sources, these OVDs offer enhanced tissue protection and healing properties, making them increasingly preferred for delicate eye surgeries. Moreover, the growing emphasis on natural and minimally invasive procedures is driving the demand for biological OVDs.

The semi-synthetic segment is anticipated to witness the fastest CAGR of 7.3% over the forecast period. This is due to their customizable properties and versatility in application. These OVDs offer a balance of biocompatibility and viscoelastic properties, making them suitable for a wide range of ophthalmic procedures. The increasing number of cataract surgeries, coupled with the preference for reliable and affordable OVDs, is fueling the demand for semi-synthetic options.

Application Insights

Based on application, the cataract surgery segment led the market with the largest revenue share of 50.9% in 2025. The increasing prevalence of cataracts, driven by an aging population and rising rates of diabetes, has significantly boosted the demand for OVDs in cataract surgery. Cataract is among leading cause of vision impairment and blindness at global level, affecting approximately 65.2 million people. According to American Academy of Ophthalmology,over 10 million cataract operations are performed each year worldwide. The use of OVDs in cataract surgery is crucial for maintaining anterior chamber stability, protecting delicate ocular tissues, and enhancing surgical visibility, thereby contributing to improved outcomes.

To learn more about this report, Download Free Sample Report

Vitreoretinal grafting is projected to grow the fastest CAGR of 6.7% over the forecast period. Vitreoretinal surgery is witnessing growing OVD usage due to the rising incidence of retinal disorders such as diabetic retinopathy and macular degeneration. According to Glaucoma Research Foundation, in US, diabetic retinopathy affects nearly 7.7 million people of age 40 and older.

Regional Insights

North America dominated the ophthalmic viscosurgical devices market with the largest revenue share of 37.7% in 2025. North America has a significant population with ophthalmic disorders such as cataracts and glaucoma, which necessitate surgical interventions. The presence of a robust healthcare infrastructure and increasing investment in research and development by key players in the market also contribute to this trend.

To learn more about this report, Download Free Sample Report

U.S. Ophthalmic Viscosurgical Devices Market Trends

The ophthalmic viscosurgical devices market in the U.S. held the largest share in the North America region in 2025. U.S. ophthalmic viscosurgical devices market dominated the North America market in 2025 due to its large geriatric population, high prevalence of chronic diseases, and extensive healthcare coverage. According to Population Reference Bureau, the number of Americans aged 65 and older projected to increase by 47% and account for 23% of the total population by 2050.

Europe Ophthalmic Viscosurgical Devices Market Trends

The Europe ophthalmic viscosurgical devices market was identified as a lucrative region in this industry due to rising geriatric population, increasing prevalence of diabetic retinopathy, and advancements in ophthalmic surgical techniques. According to European Commission, more than one fifth of European population is aged 65 years and over.

The Germany ophthalmic viscosurgical devices (OVD) market is expected to grow rapidly in the coming years due to advanced research facilities and a strong focus on innovation in medical technology. Furthermore, Germany’s demographic trends show an increasing elderly population that requires more frequent eye surgeries, thereby propelling market growth. According to National Institute of Health, about 700,000 people in Germany have cataract surgery each year.

Asia Pacific Ophthalmic Viscosurgical Devices Market Trends

Asia Pacific market is anticipated to witness fastest CAGR in the coming years. This growth is due to the burgeoning population, increasing prevalence of diabetic retinopathy, and rising disposable incomes.

The ophthalmic viscosurgical devices (OVD) market in India held a substantial share in 2023 due to its large population, rising incidence of cataracts and other eye diseases, and increasing affordability of healthcare services.

Key Ophthalmic Viscosurgical Devices Company Insights

Some of the key companies in the ophthalmic viscosurgical devices market are Bausch + Lomb, Carl Zeiss Meditec AG, Bohus BioTech AB, BVI, Nordic Pharma, Inc., Truviz Ophthalmic and others. Companies in the market are focusing on launching new products to gain a competitive edge in the industry. 

• Bausch + Lomb is an American-Canadian company specializing in eye health products. It is one of the largest suppliers of intraocular lenses, lens care products, contact lenses, pharmaceuticals, and products related to eye care.  

• Bausch + Lomb

• Carl Zeiss Meditec AG

• Johnson & Johnson Services, Inc.

• Alcon

• Rayner Group

• Bohus BioTech AB

• BVI

• Nordic Pharma, Inc.

• Truviz Ophthalmic

Recent Developments

• In April 2024, Carl Zeiss Meditec AG announced the acquisition of the Dutch Ophthalmic Research Center (D.O.R.C.). This strategic move aims to consolidate the companies' strengths and drive innovation in ophthalmic medical devices and surgery.

• In June 2024, Alcon received FDA clearance for its UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS). These are the first products from Alcon's new Unity portfolio. This clearance marks a significant milestone for Alcon, as it expands its offerings in the eye care market. The UNITY systems are expected to provide innovative solutions for cataract surgery.

Global Ophthalmic Viscosurgical Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ophthalmic viscosurgical devices market report based on type, source, application, and region.

To learn more about this report, Download Free Sample Report

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Dispersive

  • Cohesive

  • Viscoadaptive

• Source Outlook (Revenue, USD Million, 2021 - 2033)

  • Animal

  • Biological

  • Semi-synthetic

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Cataract Surgery

  • Glaucoma Surgery

  • Corneal Grafting

  • Vitreoretinal Grafting

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Mexico

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Thailand

    • Australia

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The ophthalmic viscosurgical devices market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each ophthalmic viscosurgical devices segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations